Weekly Insider Money Tracking: Corporate Executive of SMMT bought 395 million company shares

CEO Robert W Duggan of Summit Therapeutics bought a total of 376,489,880 shares at an average price of $1.05. To acquire these shares, it cost around $395.31 million. The company’s Co-CEO and CFO also acquired shares of the company. Major insider buying hints of SMMT that executives are highly confident that the programs in development will be successful.

For the top selling of this week, the Director of DoubleVerify Holdings, Inc., a digital media measurement and analytics software platform, Robert Davis Noell sold a total of 14,375,000 shares at an average price of $26.50. The insider received around $380.94 million from selling those shares.

There is no congress trading activity filings for the week.

Despite their influence and extensive access to information, members of Congress can buy and sell stocks with few restrictions. Individual investors could potentially make use of thisalternative data of the latest Senate stock disclosuresto obtainmarket insights.